+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Macular Degeneration"

From
From
From
From
From
From
Prescription Lens Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Prescription Lens Market Analysis & Forecast to 2024-2034

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Ophthalmic Devices Market - Product Thumbnail Image

Ophthalmic Devices Market

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Fundus Cameras Market by Product, by End-User, and By Region - Product Thumbnail Image

Fundus Cameras Market by Product, by End-User, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
From
Ophthalmic Microscopes Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Ophthalmic Microscopes Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

Macular Degeneration is a condition that affects the central part of the retina, known as the macula, which is responsible for sharp, central vision. It is the leading cause of vision loss in people over the age of 50. Optical treatments for Macular Degeneration include laser photocoagulation, photodynamic therapy, and anti-VEGF injections. Laser photocoagulation is used to reduce the risk of further vision loss by sealing off leaking blood vessels in the macula. Photodynamic therapy is used to reduce the growth of abnormal blood vessels in the macula. Anti-VEGF injections are used to reduce the growth of abnormal blood vessels and improve vision. Companies in the Macular Degeneration market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more